AD-SMART trial launched in the UK: diabetes and ADHD drugs to be tested in Alzheimer's patients
A clinical trial called AD-SMART has begun in the UK — a platform study testing several repurposed drugs simultaneously. The first to be tested are metformin (for type 2 diabetes) and atomoxetine (for ADHD). Around 1,200 participants with mild and moderate Alzheimer's disease are planned to be enrolled at more than 30 sites; results for the first drugs are expected by 2030.
Javlon Tursunov